This inventor holds 1 USPTO granted patent. Top assignees: George Mason University, St. Jude Children's Research Hospital, The George Washington University. Active years: 2017.
Company Filing History:
1 out of 270 
1 out of 281 
1 out of 283 
Years Active: 2017
Title: The Innovations of Robin Lee
Introduction
Robin Lee is an accomplished inventor based in Cordova, TN (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit specific enzymes. His work has implications for medical research and treatment.
Latest Patents
Robin Lee holds a patent for "Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase." This invention is particularly effective in inhibiting Dxr in Mycobacterium tuberculosis (Mtb). The compounds described in his patent have a general formula (I) or (II), showcasing his innovative approach to addressing critical health challenges.
Career Highlights
Throughout his career, Robin Lee has worked with prestigious institutions, including Washington University and George Mason University. His research has contributed to advancements in the understanding of biochemical processes and potential therapeutic applications.
Collaborations
Robin has collaborated with notable colleagues, including Helena I. Boshoff and Cynthia Dowd. These partnerships have enhanced the scope and impact of his research endeavors.
Conclusion
Robin Lee's innovative work in the field of biochemistry, particularly through his patent, demonstrates his commitment to advancing medical science. His collaborations and career achievements further highlight his significant contributions to the field.